<DOC>
	<DOCNO>NCT01856140</DOCNO>
	<brief_summary>Main purpose study evaluate efficacy safety allogenic adipose-derived mesenchymal stem cell ( ALLO-ASC ) treatment tendon injury . ALLO-ASC administrate patient lateral epicondylitis ultrasonographic guide injection .</brief_summary>
	<brief_title>Treatment Tendon Injury Using Mesenchymal Stem Cells</brief_title>
	<detailed_description>Injection volume depend size lesion ultrasound examination . And injection do ultrasound guidance . First investigator administrate 1 million cells/ml ( Group 1 6 participant ) . After monitor safety injection 2 week ( investigator use WHO recommendation grade acute subacute toxic effect ) , investigator decide increase quantity 10 million cells/ml ( Group 2 participant ) . The investigator compare efficacy difference quantity increase . For efficacy measurement , VAS/modified Mayo clinic performance index elbow/lesion measurement ultrasound use 6 12 week injection .</detailed_description>
	<mesh_term>Tennis Elbow</mesh_term>
	<mesh_term>Tendon Injuries</mesh_term>
	<criteria>clinically diagnosed lateral epicondylitis ( tennis elbow ) recurrent pain spite conservative treatment physical therapy , medication , steroid injection symptom duration 6 month defect common extensor tendon observe ultrasound patient understand clinical trial patient underwent injection treatment within 6 week associate disease ( arthritis , synovitis , entrapment relate nerve , radiculopathy target lesion , generalize pain syndrome , rheumatoid arthritis , pregnancy , impaired sensibility , paralysis , history allergic hypersensitive reaction bovinederived protein fibrin glue ) patient enrol clinical trial within 30 day history drug/alcohol addiction , habitual smoker</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>adipose derive mesenchymal stem cell</keyword>
	<keyword>allogeneic stem cell</keyword>
</DOC>